medline.ch Respirationstrakt Zystische Fibrose

	Characterization and Comparison of The "Frequent Exacerbator Phenotype" in Non-Cystic Fibrosis Bronchiectasis Patients in a TB-Endemic Country: A Hospital-Based Comparative Study. Ethiop J Health Sci Bekele SK, Neda WN, Atnafu TA, Yigzaw HD, Anley HY, Hagos EH, Yusuf H. PMID: 42006240 [PubMed - as supplied by publisher]
	Could the Phenotypic Outcomes of Genetic Variability in Cells Operating in Mechanically Dynamic Environments be Influenced by a Disrupted "Cell-ECM" Relationship? Using Cystic Fibrosis and Marfan Syndrome as an Example. Bioessays Hart DA. PMID: 42003479 [PubMed - indexed for MEDLINE]
	Lung T1-MRI and Multi-Breath Washout Detect Longitudinal Changes in Children 6-11 Years Old After Beginning Elexacaftor/Tezacaftor/Ivacaftor (ETI) Therapy. Pediatr Pulmonol Nasr SZ, Flask CA, Kretzler ME, Slaven JE, Joshi A, Mahani MG, Clem C, Cooper M, Farr S, MacAskill CJ, Gupta A, Ferrebee M, McBennett KA, Ren CL. PMID: 42003453 [PubMed - indexed for MEDLINE]
	Oral health status in adult and paediatric patients with cystic fibrosis (CF): A systematic review and meta-analysis. Paediatr Respir Rev Cuozzo A, Mauriello L, Pezzella V, Iorio-Siciliano V, Ramaglia E, Lanzillo SG, Marini L, Blasi A. PMID: 42002471 [PubMed - as supplied by publisher]
	Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function? Pediatr Pulmonol Cárdenes CML, Santamaría SV, Romero RG, González AT, Galindo CG, Castro EB, Quaresma J, Tirado AM, García MG, Martínez JRG, Merino MÁ, Rubio ET, Pérez PO, Peña-Quintana L, Reyes-Domínguez A, Nicolás SSS, Hurtado MM, Castillo RDB, Mercedes MLS, Volpe CG, Beltrán MÁ, Cavia SM, Torne CV, Jiménez DG, y Grupo de trabajo de FQ y páncreas de la SEGHNP. PMID: 41999579 [PubMed - indexed for MEDLINE]
	A case of "summer hypokalemia" revealing adult-diagnosed cystic fibrosis. Nefrologia (Engl Ed) Enes Cetin T, Baran Tomar V, Eken Y, Helvac, Guz G. PMID: 41997684 [PubMed - in process]
	Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods study. JBI Evid Implement Matson AG, Smith D, Loel F, Moore V, Herd K, Wagenaar M, Kumar S. PMID: 41995275 [PubMed - indexed for MEDLINE]
	Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis. Adv Ther Panou T, Gouveri E, Popovic DS, Papanas N. PMID: 41991874 [PubMed - as supplied by publisher]
	[CFTR-related disorders (CFTR-RD) : definition and illustration by a clinical case of reccurent acute pancreatitis in an adolescent]. Rev Med Liege Wirth L, Lhomme A, Boboli H. PMID: 41987545 [PubMed - indexed for MEDLINE]
	Psychological impact of genetic eligibility for CFTR modulator therapy in children with cystic fibrosis and their parents. Eur J Pediatr Oztosun B, Durcan G, Gulumser SB, Altug D, Gunal B, Anac E, Yavuz M, Cokugras H, Dogangun B, Kilinc Sakalli AA. PMID: 41984234 [PubMed - indexed for MEDLINE]
	Bacterial Resistance Associated With Inhaled Tobramycin for Prevention of Ventilator-Associated Tracheitis in Mechanically Ventilated Neonates and Children Without Cystic Fibrosis: An Observational Pilot Study. J Pediatr Pharmacol Ther Parman A, Shrestha M, Miller JL, Oldham MM, Neely S, Johnson PN. PMID: 41983011 [PubMed]
	Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis: A 24-Month Italian National Registry Study. J Clin Med Salvatore D, Campagna G, Padoan R, Pepe A, Amato A, Salvatore M. PMID: 41977003 [PubMed]
	Adherence to elexacaftor/tezacaftor/ivacaftor (ETI) among people with cystic fibrosis: the yETI study. Ann Am Thorac Soc Everhart RS, Ford C, Gibson SL, Riekert KA, Duncan CL, Bord E, Hoppe JE, Lyons E, Prickett M, von Isenburg M, Muther EF. PMID: 41975078 [PubMed - as supplied by publisher]
	Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Trials. Ann Am Thorac Soc Milinic T, Magaret AS, Brown CE, McElvaney OJ, Mayer-Hamblett N, Kapnadak SG, Heckbert SR, Ramos KJ, Goss CH. PMID: 41974942 [PubMed - as supplied by publisher]
	Impact of two years of treatment with Elexacaftor/Tezacaftor/Ivacaftor on longitudinal changes in structural lung disease in people with Cystic Fibrosis - Results from the RECOVER trial. Ann Am Thorac Soc McNally P, Lester K, Cregan R, Elnazir B, Persaud T, Rea D, Twomey E, Williamson M, Cox DW, Linnane B, McGrane S, Kirwan L, O'Regan P, Bonte M, Makani P, Caudri D, Dodd JD, McKone EF, Saunders C, Semple T, Davies JC, Tiddens HAWM, RECOVER study group. PMID: 41973991 [PubMed - as supplied by publisher]
	An update on cystic fibrosis Hepato-biliary involvement. J Cyst Fibros Freeman AJ, Bodewes FAJA. PMID: 41963204 [PubMed - as supplied by publisher]
	Triglyceride-related lipid changes in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor: A real-world cross-sectional study. Clin Nutr ESPEN Zamarrón E, Pérez Cuadrado A, Baloira L, Carpio C, Aguilera García I, Palma Milla S, González Pérez de Villar N, Mangas A, Mariscal P, Álvarez-Sala R, Prados MC. PMID: 41962765 [PubMed - as supplied by publisher]
	Transamniotic Fetal Delivery of Cystic Fibrosis (CF) Transmembrane Conductance Regulator (CFTR) mRNA. FASEB Bioadv Moskowitzova K, Whitlock AE, Shroff YV, Zurakowski D, Fauza DO. PMID: 41959539 [PubMed]
	Money Talks (But Do We?): Evaluating Perceptions and Practices of Financial Conversations by Cystic Fibrosis Clinicians. Pediatr Pulmonol Perkins RC, Davis J, Alao M, Allen S, Harrison M, Sawicki GS. PMID: 41952367 [PubMed - indexed for MEDLINE]
	Cystic fibrosis care today-a narrative review based on views of experts, patients and the public. Wien Klin Wochenschr Singer F, Schaffer AM, Auer M, Auer J, Pansy J, Stadlbauer V, Eber E. PMID: 41951869 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 19874

Seite 1 von 994



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung